The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way

被引:49
作者
Mediwala, Sanjay N. [1 ,2 ]
Sun, Huiying [1 ,2 ]
Szafran, Adam T. [3 ]
Hartig, Sean M. [3 ]
Sonpavde, Guru [1 ,2 ]
Hayes, Teresa G. [1 ,2 ]
Thiagarajan, Perumal [2 ,4 ]
Mancini, Michael A. [3 ]
Marcelli, Marco [1 ,2 ,3 ]
机构
[1] Baylor Coll Med, Dept Med, Houston, TX 77030 USA
[2] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA
[3] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[4] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
关键词
castration-resistant prostate cancer; AR-V7; PI3K; PROSTATE-CANCER CELLS; SIGNALING PATHWAY; PTEN EXPRESSION; PHOSPHOINOSITIDE; 3-KINASE; FREQUENT INACTIVATION; SPLICE VARIANTS; MOUSE MODEL; ACTIVATION; AKT; THERAPY;
D O I
10.1002/pros.22566
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND The androgen receptor (AR) AR-V7 splice isoform is a constitutively active outlaw transcription factor. Transition of prostate cancer (PC) to the castration-resistant phenotype correlates with AR-V7 accumulation, suggesting that PC progression in patients refractory to conventional therapy is due to the activity of this AR isoform. The mechanism of AR-V7 constitutive activation is not known. METHODS We analyzed potential signaling pathways associated with AR-V7 constitutive activation in PTEN (-) PC-3 and LNCaP cells. We used transient and stable transfection, reporter gene assay, RNAi technology together with a number of kinase inhibitors to determine if AR-V7 activation is linked to a kinase-dependent signaling pathway. RESULTS In these cell lines, AR-V7 transcriptional activity was inhibited by LY294002, Wortmanin, and AKT inhibitor II. Analysis of the contributing mechanisms demonstrated the involvement of the Phosphatidylinositol 3-kinase (PI3K)-AKT-FOXO1 signaling pathway, and a significant reduction of AR-V7 constitutive activity under conditions of PTEN reactivation. CONCLUSIONS Our study identifies a pathway regulating AR-V7 constitutive activity and potential therapeutic targets for the treatment of castration-resistant PC. Prostate 73: 267277, 2013. (c) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:267 / 277
页数:11
相关论文
共 51 条
  • [1] Mechanism of activation of protein kinase B by insulin and IGF-1
    Alessi, DR
    Andjelkovic, M
    Caudwell, B
    Cron, P
    Morrice, N
    Cohen, P
    Hemmings, BA
    [J]. EMBO JOURNAL, 1996, 15 (23) : 6541 - 6551
  • [2] Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression end Akt activation
    Bedolla, Roble
    Prihoda, Thomas J.
    Kreisberg, Jeffrey I.
    Malik, Shazli N.
    Krishnegowda, Naveen K.
    Troyer, Dean A.
    Ghosh, Paramita M.
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (13) : 3860 - 3867
  • [3] Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
    Biggs, WH
    Meisenhelder, J
    Hunter, T
    Cavenee, WK
    Arden, KC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) : 7421 - 7426
  • [4] Cairns P, 1997, CANCER RES, V57, P4997
  • [5] Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
    Carver, Brett S.
    Chapinski, Caren
    Wongvipat, John
    Hieronymus, Haley
    Chen, Yu
    Chandarlapaty, Sarat
    Arora, Vivek K.
    Le, Carl
    Koutcher, Jason
    Scher, Howard
    Scardino, Peter T.
    Rosen, Neal
    Sawyers, Charles L.
    [J]. CANCER CELL, 2011, 19 (05) : 575 - 586
  • [6] Molecular determinants of resistance to antiandrogen therapy
    Chen, CD
    Welsbie, DS
    Tran, C
    Baek, SH
    Chen, R
    Vessella, R
    Rosenfeld, MG
    Sawyers, CL
    [J]. NATURE MEDICINE, 2004, 10 (01) : 33 - 39
  • [7] Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance
    Dehm, Scott M.
    Schmidt, Lucy J.
    Heemers, Hannelore V.
    Vessella, Robert L.
    Tindall, Donald J.
    [J]. CANCER RESEARCH, 2008, 68 (13) : 5469 - 5477
  • [8] Dubrovska A, CLIN CANC RES, V16, P5692
  • [9] Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor
    Fan, WuQiang
    Yanase, Toshihiko
    Morinaga, Hidetaka
    Okabe, Taijiro
    Nomura, Masatoshi
    Daitoku, Hiroaki
    Fukamizu, Akiyoshi
    Kato, Shigeaki
    Takayanagi, Ryoichi
    Nawata, Hajime
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (10) : 7329 - 7338
  • [10] Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
    Gao, Hui
    Ouyang, Xuesong
    Banach-Petrosky, Whitney A.
    Gerald, William L.
    Shen, Michael M.
    Abate-Shen, Cory
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (39) : 14477 - 14482